ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry - ResMed (NYSE:RMD)
ResMed Inc (NYSE: RMD) posted Q4 adjusted EPS of $1.60, up from $1.49 a year ago, missing the consensus of $1.67.
Source: benzinga.com